Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged drug development · clear
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that time, Roche Products Inc. held patent rights for flurazepam hydrochloride, the active ingredient in the drug.…
Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound like a good industry to be in, but keep in mind that the costs of developing a new drug range from $300 million up to…
ACTION : Infringement of U.S. Patent 5,827,529 (referred to as “529 Patent) by Noven Therapeutics/ Noven Pharmaceuticals , makers of products such as the ADHD drug Daytrana, at a considerable harm to the transdermal drug delivery technology company…
In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia (CML). Since its release, imatinib has offered hope for patients suffering from (CML);…
